These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9210184)

  • 21. Electrostatics of pharmaceutical inhalation aerosols.
    Kwok PC; Chan HK
    J Pharm Pharmacol; 2009 Dec; 61(12):1587-99. PubMed ID: 19958580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers.
    Saini D; Biris AS; Srirama PK; Mazumder MK
    Pharm Dev Technol; 2007; 12(1):35-41. PubMed ID: 17484142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dry powder inhaler with reduced mouth-throat deposition.
    Wang ZL; Grgic B; Finlay WH
    J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems.
    Young PM; Sung A; Traini D; Kwok P; Chiou H; Chan HK
    Pharm Res; 2007 May; 24(5):963-70. PubMed ID: 17377746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers?
    Olsson B
    J Aerosol Med; 1995 Sep; 8 Suppl 3():S13-8; discussion S19. PubMed ID: 10172642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
    Jones MD; Buckton G
    Int J Pharm; 2016 Jul; 509(1-2):419-430. PubMed ID: 27265314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
    Jetmalani K; Young PM; Smith T; Stewart P; Traini D
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1504-11. PubMed ID: 22335558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.
    Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
    J Pharm Sci; 2007 May; 96(5):1302-19. PubMed ID: 17455364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of budesonide nanocluster dry powder aerosols: preformulation.
    El-Gendy N; Selvam P; Soni P; Berkland C
    J Pharm Sci; 2012 Sep; 101(9):3434-44. PubMed ID: 22623018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U; Marschall K; Fyrnys B; Wedel M
    Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of electrostatic behavior of a lactose carrier for dry powder inhalers.
    Chow KT; Zhu K; Tan RB; Heng PW
    Pharm Res; 2008 Dec; 25(12):2822-34. PubMed ID: 18581205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.
    Lucas P; Anderson K; Staniforth JN
    Pharm Res; 1998 Apr; 15(4):562-9. PubMed ID: 9587952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
    Chew NY; Chan HK
    J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2015 Sep; 32(9):2928-36. PubMed ID: 25788449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does electrostatic charge affect powder aerosolisation?
    Adi H; Kwok PC; Crapper J; Young PM; Traini D; Chan HK
    J Pharm Sci; 2010 May; 99(5):2455-61. PubMed ID: 19941330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
    Raula J; Rahikkala A; Halkola T; Pessi J; Peltonen L; Hirvonen J; Järvinen K; Laaksonen T; Kauppinen EI
    Int J Pharm; 2013 Jan; 441(1-2):248-54. PubMed ID: 23200957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.
    Mortensen J; Groth S; Lange P; Hermansen F
    Thorax; 1991 Nov; 46(11):817-23. PubMed ID: 1771605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.